Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/2/17 → 01/16/20 |
Funding
- Incyte Corporation: $16,795.00
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research